Location: Canada, Ontario, Toronto
Total raised: $20M
Investors 1
| Date | Name | Website |
| - | Esperante | esperante.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.08.2022 | - | $20M | - |
Mentions in press and media 8
| Date | Title | Description |
| 30.04.2024 | Medicenna Therapeutics Announces Closing of CA$20 Million Investment from RA Capital Management | - |
| 26.04.2024 | Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management | - |
| 26.04.2024 | Medicenna Therapeutics Announces CA$20 Million Investment from RA Capital Management | Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 26, 2024 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA) (MDNAF: OTCQB... |
| 06.03.2024 | Medicenna to Provide Clinical Update on the MDNA11 ABILITY-1 Trial at the Upcoming American Association for Cancer Research Annual Meeting | - |
| 25.11.2020 | MEDICENNA THERAPEUTICS CORP. Medicenna Therapeutics : Q2 Financial Statements | Interim condensed consolidated financial statements of Medicenna Therapeutics Corp. (Expressed in Canadian Dollars) For the three and six months ended September 30, 2020 Medicenna Therapeutics Corp. Interim Condensed Consolidated Statements... |
| 25.11.2020 | MEDICENNA THERAPEUTICS CORP. Medicenna Therapeutics : Q2 Management's Discussion & Analysis | Management's Discussion and Analysis For the Three and Six Months Ended September 30, 2020 DATE OF REPORT: November 12, 2020 MANAGEMENT'S DISCUSSION AND ANALYSIS The following management's discussion and analysis ("MD&A") has ... |
| 25.11.2020 | Medicenna Therapeutics : Q2 Financial Statements | Interim condensed consolidated financial statements of Medicenna Therapeutics Corp. (Expressed in Canadian Dollars) For the three and six months ended September 30, 2020 Medicenna Therapeutics Corp. Interim Condensed Consolidated Statements... |
| 25.11.2020 | Medicenna Therapeutics : Q2 Management's Discussion & Analysis | Management's Discussion and Analysis For the Three and Six Months Ended September 30, 2020 DATE OF REPORT: November 12, 2020 MANAGEMENT'S DISCUSSION AND ANALYSIS The following management's discussion and analysis ("MD&A") has ... |